S'abonner

Relation of Anterior Cruciate Ligament Tears to Potential Chronic Cardiovascular diseases - 13/11/18

Doi : 10.1016/j.amjcard.2018.08.030 
William P. Meehan, MD b, c, 1, Marc G. Weisskopf, PhD j, 1, Supriya Krishnan, DSc a, Caitlin McCracken, MA a, Ross Zafonte, DO d, Herman A. Taylor, MD a, e, Aaron Baggish, MD f, Alvaro Pascual-Leone, MD, PhD g, Lee M. Nadler, MD h, Frank E. Speizer, MD i, j,
a Football Players Health Study at Harvard University, Harvard Medical School, Boston, Massachusetts 
b Micheli Center for Sports Injury Prevention, Waltham, Massachusetts 
c Division of Sports Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 
d Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts 
e Cardiovascular Research Institute, Department of Medicine, Morehouse School of Medicine, Atlanta, Georgia 
f Cardiovascular Performance Program, Massachusetts General Hospital Department of Medicine, Harvard Medical School, Boston, Massachusetts 
g Berenson-Allen Center and Division for Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 
h Dana Farber Cancer Center, Harvard Medical School, Boston, Massachusetts 
i Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 
j Department of Environmental Health and Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts 

Corresponding author: Tel: 617-998-6008; fax: 617-384-5131.

Résumé

We have enrolled a cohort of former National Football League players (n = 3,506) who played since 1960 to assess potential long term health consequences associated with participating in the sport. Each participant has completed a self-administered questionnaire including reporting of physician-diagnosed health conditions. One of the early assessments was to evaluate whether anterior cruciate ligament (ACL) tears were associated with later life co-morbidities, including cardiovascular effects. We used Cox proportional hazards to estimate hazard ratios (HR) for joint replacement surgeries, myocardial infarction, sleep apnea, arthritis, dementia, and stroke by history of ACL tear during their professional career. For additional outcomes without date of occurrence reported we used logistic regression to estimate odds ratios adjusted for potential confounding variables in all models. After adjusting for covariates, former National Football League players who tore their ACL had approximately a twofold increase in muscular skeletal co-morbidities, including knee joint replacement and arthritis, compared with those without ACL tears. In addition, those with a history of ACL tears also had more than a 50% increased risk of myocardial infarction (HR 1.52; 95% confidence interval 0.97 to 2.38) and a slight increase in sleep apnea (HR 1.15; 95% confidence interval 0.96 to 1.38). ACL tears sustained by athletes may increase the risk of co-morbidities beyond the musculoskeletal system. As there are more than 100,000 ACL reconstructions annually in the United States, our findings could have widespread public health importance if these findings generalize to a population beyond professional football players. In conclusion, enhanced screening for other risk factors for these conditions in patients who have torn their ACL might identify those who could most benefit from prevention strategies.

Le texte complet de cet article est disponible en PDF.

Plan


 Source of Funding: Dr. Zafonte receives royalties from (1) Oakstone for an educational CD-Physical Medicine and Rehabilitation a Comprehensive Review; (2) Demos publishing for serving as coeditor of the text Brain Injury Medicine. Dr. Zafonte serves on the Scientific Advisory Board of Oxeia Biopharma and Myomo. He also evaluates patients in the MGH Brain and Body-TRUST Program which is funded by . Dr. Zafonte was partially supported by: NIDLIRR: 90DP0039-03-00, 90SI5007-02-04,90 D P0060; USAMRC-W81XWH-1120210, NIH: 4 U01NS086090-04; 5R24HD082302-02;5U01NS091951-03 and by a grant from the Football Players Health Study at Harvard University, which is funded by the NFL Players AssociationDr. A. Pascual-Leone was partly supported by the Sidney R. Baer Jr. Foundation, the NIH (R01MH100186, R01HD069776, R01NS073601, R21 NS082870, R21 MH099196, R21 NS085491, R21 HD07616), the Football Players Health Study at Harvard University, and Harvard Catalyst | The Harvard Clinical and Translational Science Center (NCRR and the NCATS NIH, UL1 RR025758).
Grant Support: The Football Players Health Study is funded by a grant from the National Football League Players Association (Washington, DC, USA).


© 2018  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 122 - N° 11

P. 1879-1884 - décembre 2018 Retour au numéro
Article précédent Article précédent
  • Physical Activity Intensity and Cardiovascular Disease Prevention—From the Seguimiento Universidad de Navarra Study
  • Maria Hidalgo-Santamaria, Maira Bes-Rastrollo, Miguel Angel Martinez-Gonzalez, Laura Moreno-Galarraga, Miguel Ruiz-Canela, Alejandro Fernandez-Montero
| Article suivant Article suivant
  • Extended Cardiac Monitoring in Patients With Severe Sleep Apnea and No History of Atrial Fibrillation (The Reveal XT-SA Study)
  • Cynthia Yeung, Doran Drew, Sharlene Hammond, Wilma M. Hopman, Damian Redfearn, Christopher Simpson, Hoshiar Abdollah, Adrian Baranchuk

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.